ALHC Relative Valuation
ALHC's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ALHC is overvalued; if below, it's undervalued.
Historical Valuation
Alignment Healthcare Inc (ALHC) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -74.49. The fair price of Alignment Healthcare Inc (ALHC) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：19.40
Fair
97.00
PE
1Y
3Y
5Y
Trailing
Forward
27.35
EV/EBITDA
Alignment Healthcare Inc. (ALHC) has a current EV/EBITDA of 27.35. The 5-year average EV/EBITDA is -82.05. The thresholds are as follows: Strongly Undervalued below -715.34, Undervalued between -715.34 and -398.70, Fairly Valued between 234.59 and -398.70, Overvalued between 234.59 and 551.24, and Strongly Overvalued above 551.24. The current Forward EV/EBITDA of 27.35 falls within the Historic Trend Line -Fairly Valued range.
36.07
EV/EBIT
Alignment Healthcare Inc. (ALHC) has a current EV/EBIT of 36.07. The 5-year average EV/EBIT is -5.12. The thresholds are as follows: Strongly Undervalued below -293.82, Undervalued between -293.82 and -149.47, Fairly Valued between 139.23 and -149.47, Overvalued between 139.23 and 283.58, and Strongly Overvalued above 283.58. The current Forward EV/EBIT of 36.07 falls within the Historic Trend Line -Fairly Valued range.
0.79
PS
Alignment Healthcare Inc. (ALHC) has a current PS of 0.79. The 5-year average PS is 1.27. The thresholds are as follows: Strongly Undervalued below -0.73, Undervalued between -0.73 and 0.27, Fairly Valued between 2.26 and 0.27, Overvalued between 2.26 and 3.26, and Strongly Overvalued above 3.26. The current Forward PS of 0.79 falls within the Historic Trend Line -Fairly Valued range.
36.78
P/OCF
Alignment Healthcare Inc. (ALHC) has a current P/OCF of 36.78. The 5-year average P/OCF is -39.03. The thresholds are as follows: Strongly Undervalued below -190.01, Undervalued between -190.01 and -114.52, Fairly Valued between 36.46 and -114.52, Overvalued between 36.46 and 111.94, and Strongly Overvalued above 111.94. The current Forward P/OCF of 36.78 falls within the Overvalued range.
50.29
P/FCF
Alignment Healthcare Inc. (ALHC) has a current P/FCF of 50.29. The 5-year average P/FCF is 154.33. The thresholds are as follows: Strongly Undervalued below -1219.45, Undervalued between -1219.45 and -532.56, Fairly Valued between 841.23 and -532.56, Overvalued between 841.23 and 1528.12, and Strongly Overvalued above 1528.12. The current Forward P/FCF of 50.29 falls within the Historic Trend Line -Fairly Valued range.
Alignment Healthcare Inc (ALHC) has a current Price-to-Book (P/B) ratio of 23.97. Compared to its 3-year average P/B ratio of 14.26 , the current P/B ratio is approximately 68.08% higher. Relative to its 5-year average P/B ratio of 12.61, the current P/B ratio is about 90.07% higher. Alignment Healthcare Inc (ALHC) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -3.76%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -3.15% , the current FCF yield is about -100.00% lower.
23.97
P/B
Median3y
14.26
Median5y
12.61
3.94
FCF Yield
Median3y
-3.76
Median5y
-3.15
Competitors Valuation Multiple
The average P/S ratio for ALHC's competitors is , providing a benchmark for relative valuation. Alignment Healthcare Inc Corp (ALHC) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 43.51%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of ALHC increased by 72.44% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -76.39 to -182.48.
The secondary factor is the Revenue Growth, contributed 43.51%to the performance.
Overall, the performance of ALHC in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch
FAQ
Is Alignment Healthcare Inc (ALHC) currently overvalued or undervalued?
What is Alignment Healthcare Inc (ALHC) fair value?
How does ALHC's valuation metrics compare to the industry average?
What is the current P/B ratio for Alignment Healthcare Inc (ALHC) as of Dec 05 2025?
What is the current FCF Yield for Alignment Healthcare Inc (ALHC) as of Dec 05 2025?
What is the current Forward P/E ratio for Alignment Healthcare Inc (ALHC) as of Dec 05 2025?